Publications

Peer-reviewed Original Investigations (lead or corresponding author)

  1. Copy Torres-Cabala CA, Arreola Yescas J, Zhang Y, Huen A, Sumit G, Tefft K, Tang G, Curry JL, Gunther J, Dabaja B, Iyer S, Miranda RN, Choi J*, and Nardi V.* Primary cutaneous cd8+ aggressive epidermotropic cytotoxic t-cell lymphoma with novel FGFR1 fusion treated with pemigatinib. Blood Advances. In Press *Co-corresponding author
  2. Myers CS, Williams E, Cornejo CB, Pongas G, Toomey NL, Sanches JA, Battestella M, Mo S, Pulitzer M, Moskaluk C, Bhagat G, Ofori K, Davick JJ, Servitje O, Miyashiro D, Climent F, Ringbloom K, Duenas DD, Law C, Casavilca S, Malpica L, Beltran BE, Castro D, Barreto L, Brites C, Chapman JR, Choi J*, Gru AA*, Ramos JC*. Distinctive genomic features of HTLV-1 related adult T-cell leukemia-lymphoma in Western populations. Haematologica. 2024 Dec 1;109(12):4021-4039. PMID: 39113648. PMCID: PMC11609816. *Co-corresponding author
  3. Reinstein ZZ, Zhang Y, Ospina O, Nichols M, Chu V, de Mingo Pulido A, Nguyen J, Yin R, de Moran Segura C, Usman A, Sell B, Ng S, de la Iglesia J, Chandra S, Sosman J, Cho RJ, Cheng JB, Ivanova EN, Koralov SB, Slebos R, Chung CH, Khushalani NI, Messina JL, Sarnaik AA, Zagen JS, Sondak VK, Vaske C, Kim S, Brohl A, Mi X, Pierce BG, Fridley BL, Tsai KY, Choi J*. Pre-existing skin-resident CD8 and gd T cell circuits mediate immune response in Merkel cell carcinoma and predict immunotherapy efficacy. Cancer Discovery. 2024. Sep 4;14(9):1631-1652. PMID: 39058036. *Co-corresponding author
  4. Law C, Wacleche VS, Cao Y, Pillai A, Sowerby J, Hancock B, Horisberger A, Barcero S, Skidanova V, Li Z, Adejoorin I, Dillon E, Benque IJ, Nunez DP, Simmons DP, Keegan J, Chen L, Baker T, Brohawn PZ, Al-Mossawi H, Hao LY, Jones B, Rao N, Qu Y, Alves SE, Accelerating Medicines Partnership RA/SLE Network, Jonsson AH, Shaw KS, Vleugels RA, Massarotti E, Costenbader KH, Brenner MB, Lederer JA, Hultquist JF, Choi J*, Rao DA*. Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus. Nature. 2024. Jul;631(8022):857-866. PMID: 38987586. *Co-corresponding author
  5. Garcia J, Daniels J, Lee Y, Zhu I, Cheng K, Liu Q, Goodman D, Burnett C, Law C, Theinpont C, Alavi J, Azimi C, Montgomery G, Roybal KT*, Choi J*. Naturally Occurring T cell mutations enhance engineered T cell therapies. Nature. 2024. Feb;626(7999):626-634. PMID: 38326614. *Co-corresponding author
  6. Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, Morrish E, Venkatasubramani A, Cernilogar FM, van Heijster FHA, Hundshammer C, Schneider H, Konstantinidis F, Gabler JV, Klement C, Kurniawan H, Law C, Lee Y, Choi S, Guitart J, Forne I, Giustinani J, Muschen M, Jain S, Weinstock DM, Rad R, Ortonne N, Schilling F, Schotta G, Imhof A, Brenner D, Choi J*, Ruland J*. PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma. Nature Cancer. 2023 Oct;4(10):1508-1525. PMID: 37723306. PMCID: PMC10597841. *Co-corresponding author
  7. Daniels J, Choi J*. BACH2 is a putative T cell lymphoma tumor suppressor that may play a role in product-derived CAR-T cell lymphomas. Blood 2021 Dec 23;138(25):2731-2733. PMID: 34499707. *corresponding author
  8. Lee, K, Evans MG, Yang L, Ng Spencer, Snowden C, Khodadost M, Brown RA, Trum NA, Querfeld C, Doan LT, Song J, Zhang H, Gru A, Wood GS, Wada DA, Shnmugam V, Haun PL, Aster J, Duncan L, Guitart J, Weinstock DM, Nardi V*, Choi J*. Primary Cytotoxic T Cell Lymphomas Harbor Recurrent Targetable Alterations in the JAK-STAT Pathway. Blood. 2021 Dec 9; 138(23):2435-2440. PMID: 34432866. co-corresponding authors

 *Featured in Blood Commentary. “Oncogenic fusions JAK up CD8+ cytotoxic CTCL.”

  1. Qian Y, Arellano G, Ifergan I, Lin J, Snowden CK, Kim T, Thomas JJ, Law C, Balabanov RD, Guan T, Kaech SM, Miller SD, Choi J*. ZEB1 Promotes Pathogenic Th1 and Th17 Cell Differentiation in Autoimmune Disease. Cell Reports. 2021 Aug. 38(8). PMID: 34433042. *co-corresponding author

  2. Zhou XA, Yang J, Ringbloom KG, Martinez-Escala ME, Stevenson KE, Wenzel AT, Fantini D, Moy AP, Morgan EA, Harkins SK, Paxton CN, Hong B, Andersen EF, Guitart J, Weinstock DM, Cerroni L, Choi J*, Louissaint A*. Genomic Landscape of Cutaneous Follicular Lymphomas Reveal Two Subgroups with Clinically Predictive Molecular Features. Blood Advances. 2021 Feb. 5(3): 649-661. *co-corresponding author. 

  3. Park J, Daniels J, Wartewig T, Ringbloom KG, Martinez-Escala ME, Choi S, Thomas JJ, Doukas PG, Yang J, Snowden C, Law C, Lee Y, Lee K, Zhang Y, Conran C, Tegtmeyer K, Mo SH, Pease DR, Jothishankar B, Kwok PY, Abdulla FR, Pro B, Louissaint A, Boggon T, Sosman J, Guitart J, Rao DA, Ruland J*, Choi J*. Integrated Genomic Analyses of Cutaneous T Cell Lymphomas Reveal the Molecular Bases for Disease Heterogeneity. Blood. 2021 Oct 7;138(14):1225-1236. PMID: 34115827. *co-corresponding authors

Featured in Blood Commentary. “PD-1 loss and T cell exhaustion in CTCL tumoral T cells.”

  1. Daniels J, Doukas PG, Martinez-Escala ME, Ringbloom KG, Shih DJH, Yang J, Tegtmeyer K, Park J, Thomas JJ, Selli ME, Altunbulakli C, Gowthaman R, Mo SH, Jothishankar B, Pease DR, Pro B, Abdulla FR, Shea C, Sahni N, Gru AA, Pierce BG, Louissiant A, Guitart J, Choi J.* Cellular Origins and Genetic Landscape of Cutaneous Gamma Delta T Cell Lymphomas. Nature Communications. 2020 April. 11(1806). PMID: 32286303  *corresponding author

Named one of the Editor’s weekly highlights

  1. Zhou XA, Louissaint A, Wenzel A, Yang J, Martinez-Escala ME, Moy AP, Morgan EA, Paxton CN, Hong B, Andersen EF, Guitart J, Behdad A, Cerroni L, Weinstock DA, Choi J.* Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B Cell Lymphoma, Leg Type. J Invest Dermatol. 2018 Nov; 138(11):2365-76. PMID: 29857068. *corresponding author

  2. Gmyrek GB, Pingel J, Choi J**, Green JM**. Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma. Cell Immunology. 2017 Sep;319:28-34. PMID: 28711152. **co-corresponding author

  3. Park J, Yang J, Wenzel AT, Ramachandran A, Lee WJ, Daniels JC, Kim J, Martinez-Escala E, Amankulor N, Pro B, Guitart J, Mendillo ML, Savas JN, Boggon TJ, Choi J*. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). Blood. 2017 Sep 21;130(12):1430-1440. PMID: 28694326. *corresponding author

Featured in Inside Blood Commentary. “Expanding and expounding the genomic map of CTCL.”

  1. King B, Lee A, Choi J*. Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. Journal of Invest Dermatol. 2017 Apr; 137(4): 951-954. PMID: 27887955. *senior author.

  2. Walker S, Wang C, Walradt T, Hong BS, Tanner JR, Levinsohn JL, Goh G, Subtil A, Lessin SR, Heymann WR, Vonderheid EC, King BA, Lifton RP, and Choi J*. Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome. Blood, 2016 Feb; 127(7):948-51. PMID: 26702067.  *corresponding author

  3. Goh, G, Walradt T, Markarov V, Blom A, Riaz N, Doumani R, Stafstrom K, Moshiri A, Yelistratova L, Levinsohn J, Chan TA, Nghiem P, Lifton RP**, and Choi J**. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. 2016 Jan;7(3):3403-15. PMID: 26655088. PMCID: PMC4823115. **co-corresponding author

Profiled by F1000

  1. Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, Carlson K, Overton JD, Liu KJ, Lewis JM, Devine L, Barbarotta L, Foss FM, Subtil A, Vonderheid EC, Edelson RL, Schatz DG, Boggon TJ, Girardi M, Lifton RP. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015 Sep;47(9):1011-9 PMID: 26192916.

  2. Choi J**, Landrette SF, et al. Identification of PLX4032-Resistance Mechanisms and Implications for Novel RAF Inhibitors. Pigment Cell Melanoma Res. 2014 Mar; 27(2):253-262. PMID: 24283590 **co-corresponding author

  3. Choi J, Walker J, Talbert-Stagle K, Wright P, Pober JS, Alexander L.  Endothelial cells promote HIV replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.  J Virol. 2005 Sept;79(17):11194-204. PMID: 16103171

  4. Choi J, Walker J, Boichuk S, Kirkiles-Smith N, Torpey N, Pober JS, Alexander L.  Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.  J Virol. 2005 Jan;79(1):264-76. PMID: 15596822
     

Peer-reviewed Original Investigations (contributing author)

  1. Kim D, Kim G, Yu R, Lee J, Kim S, Gleason MR, Qiu K, Montauti E, Wang LL, Fang D, Choi J, Chandel NS, Weinberg S, and Min, B. LAG3 Supports Foxp3+ Regulatory T Cell Function by Restraining Myc-Dependent Metabolic Reprogramming. Immunity. 2024 Nov 12;57(11):2634-2650.e5

  2. Akaike T, Thakuria M, Silk AW, Hippe DS, Park SY, So NA, Maloney NJ, Gunnell L, Eschholz A, Kim EY, Sinha S, Hall ET, Bhatia S, Reddy S, Augusto Rodriguez A, Aleshin A, Choi JS, Tsai KY, Yom SS, Yu SS, Choi J, Chandra S, Nghiem P, and Zaba L. Circulating tumor DNA assay detects Merkel cell carcinoma recurrence, disease progression, and minimal residual disease: surveillance and prognostic implications. J Clin Oncol. 2024 Sep 10;42(26):3151-3161. PMID: 39052958. PMCID: PMC11379364.  

  3. Iamsawat S, Yu R, Kim S, Dvorina N, Qiu K, Choi J, Baldwin WM, Min B. Single-cell Analysis Uncovers Striking Cellular Heterogeneity of Lung-Infiltrating Regulatory T Cells during Eosinophilic versus Neutrophilic Allergic Airway Inflammation. J Immunol. 2024 Jun 15;212(12):1867-1876. PMID: 38647384.

  4. Chung C, Wu B, LeWitt T, Griffin T, Hooper M, Zhou XA, Choi J, Guitart J. Interstitial mycosis fungoides: A rare presentation of mycosis fungoides with overlapping granulomatous and folliculotropic features. J Cutan Pathol. 2024 Jun;51(6):459-467. PMID: 38443749.

  5. Assatova B, Willim R, Trevisani C, Haskett G, Kariya K, Chopra K, Park S, Tolstorukov M, McCabe S, Duffy J, Louissaint A, Huuhtanen J, Bhattacharya D, Mustjoki S, Koh MJ, Powers F, Morgan E, Yang L, Pickney B, Cotton M, Crabbe A, Ziemba J, Brain I, Heavican-Foral T, Iqbal J, Nemec R, Rider A, Ford J, Koh M, Scanlan N, Feith D, Loughran T, Kim W, Choi J, Roels J, Boehme L, Putteman T, Taghon T, Barnes J, Johnson P, Jacobsen E, Greenberg S, Weinstock D, and Jain S. KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes. Clinical Cancer Research. 2024 Jun 3;30(11):2514-2530. PMID: 38252421. 

  6. Mohsin N, Hunt D, Yan J, Jabbour AJ, Nghiem P, Choi J, Zhang Y, Freeman AF, Bergerson JRE, Dell'Orso S, Lachance K, Kulikauskas R, Collado L, Cao W, Lack J, Similuk M, Seifert BA, Ghosh R, Walkiewicz MA, Brownell I. Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. JAMA Dermatol. 2024 Feb1;160(2):172-178. PMID: 38170500.

  7. Wu D, Hailer AA, Wang S, Yuan M, Chan J, El Kurdi A, Han D, Ali H, D’Angio B, Mayar A, Rahim M, Kondo A, Klufas D, Kim E, Shain AH, Choi J, Bhutani T, Simpson G, Grekin RC, Ricardo-Gonzalez R, Purdom E, North JP, Cheng JB, Cho RJ. A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Sci Immunol. 2024 Jan 26;9(92) Epub. PMID: 38277466

  8. Nguyen M, LeWitt T, Pang Y, Bagnowski K, Espinosa ML. Choi J, Guitart J, Liszewski W, Zhou XA. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study. Arch Dermatol Res. 2023 Mar;315(2):275-278. PMID: 35668201.

  9. Hooper MJ, Veon FL, Enriquez GL, Ngueyn M, Grimes CB, LeWitt TM, Pang Y, Case S, Choi J, Guitart J, Burns MB, Zhou XA. Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients. J Am Acad Dermatol. 2023 Feb;88(2):329-337. PMID: 36265823.

  10. Zhao L, Hsiao T, Stonesifer C, Daniels J, Garcia-Saleem TJ, Choi J, Geskin L, Rook AH, and Wood GS. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in CTCL Can be Reproduced by delta Np73 Depletion. J Invest Dermatol. 2022 Dec; 142(12):3253-3261. PMID: 35787399.

  11. Hooper MJ, Enriquez GL, Veon FL, LeWitt TM, Sweeney D, Green SJ, Seed PC, Choi J, Guitart J, Burns MB, and Zhou XA. Narrowband ultraviolet B response in cutaneous T-cell lymphoma is characterized by increased bacterial diversity and reduced Staphylococcus aureus and Staphylococcus lugdunensis. Front Immunol. 2022 Nov 11; 13:1022093. PMID: 36439132.

  12. Chung C, Espinosa M, Walker C, Choi J, Zhou XA, DeWitt T, Liszewski W, Guitart J. Acceleration of Skin Involvement as a Predictor of Disease Progression in Early-Stage Mycosis Fungoides: A Retrospective Cohort Study. J Am Acad Dermatol. 2022 Nov;87(5):1140-1141. PMID: 35167923

  13. Church C, Pulliam T, Longino N, Park SY, Smythe KS, Makarov V, Riaz N, Jing L, Amezquita R, Campbell JS, Gottardo R, Pierce RH, Choi J, Chan TA, Koelle DM, Nghiem P. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma. J Immunother Cancer. 2022 Sep; 10(9):e005328. PMID: 36252564.

  14. Hooper MJ, Veon FL, LeWitt TM, Chung C, Choi J, Zhou XA, Guitart J. Cutaneous T-Cell-Rich Lymphoid Infiltrates After SARS CoV-2 Vaccination. JAMA Dermatol. 2022 Sep 1;158(9):1073-1076. PMID 35857292.

  15. Hooper MJ, LeWitt TM, Pang Y, Veon FL, Chlipala GE, Feferman L, Green SL, Sweeney D, Bagnowski KT, Burns MB, Seed PC, Choi J, Guitart J, Zhou XA. Gut dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease. J Eur Acad Dermatol Venerol. 2022 Sep;36(9):1552-1563. PMID: 35366365.

  16. Cook C, Taylor M. Liu Y. Schmidt A, Kim E, Hailer A, North J, Harirchan P, Wong H, Kashem S, Shou Y, McCalmont T, Benz S, Choi J, Purdom E, Marson A, Ramos S, Cheng J, and Cho R. A single-cell transcriptional gradient in human cutaneous memory T cells suppresses pathogenic Th17 inflammation. Cell Reports Medicine. 2022 Aug 16; 3(8):100715. PMID: 35977472.

  17. Zaidi AJ, Choi J, Nardone B, Liszewski W. Differences in Merkel cell carcinoma survival by site of primary presentation. J Am Acad Dermatol. 2022 May;86(5):1120-1123. PMID: 33882278. 

  18. Liu Y, Wang H, Taylor M, Cook C, Martinez-Berdeja A, North JP, Harirchan P, Hailer AA, Zhao Z, Ghadially R, Ricardo-Gonzalez RR, Grekin RC, Mauro TM, Kim E, Choi J, Purdom E, Cho RJ, Cheng JB. Classification of human chronic inflammatory skin disease based on single-cell profiling. Science Immunology. 2022 Apr 15;7(70). PMID: 35427179.

  19. Raval NS, Snowden CS, De Monnin KS, Yokoyama CC, Choi J, Mehta-Shah N, Rosman IS, Pavlisin J, Musiek AC. Scarring alopecia developing after mogamulizumab-associated rash. Eur J Dermatol. 2021 Dec 1;31(6):841-843. PMID: 35107074

  20. Nihal M, Wu J, Stonesifer CJ, Daniels J, Choi J, Geskin L, Rook AH, Wood GS. Epigenetic Regulation of Apoptosis in Cutaneous T-cell Lymphoma: Implications for Therapy with Methotrexate, JAK Inhibitors, and Resveratrol. J Invest Dermatol. 2022 Feb;142(2):493-496. PMID: 34358529.

  21. Nguyen QT, Kim D, Iamaswat S, Le HT, Kim S, Qiu KT, Hinds TD, Baseley P, O’Shea JJ, Choi J, Asosingh K, Erzurum SC, Min B. Steroid responsiveness in Foxp3+ regulatory T cells determines steroid responsiveness in allergic airway inflammation in mice. J Immunol. Cutting Edge 2021 Aug. 207(3): 765-770. PMID: 34301840.

  22. Liu Y, Cook C, Sedgewick AJ, Zhang S, Fassett MS, Ricardo-Gonzalez RR, Harirchian P, Kashem SW, Hanakawa S, Leistico JR, North JP, Taylor MA, Zhang W, Man M-Q, Charruyer A, Beliakova-Bethell N, Benz SC, Ghadially R, Mauro TM, Kaplan DH, Kabashima K, Choi J, Song JS, Cho RJ, Cheng JB. Single-Cell Profiling Reveals Divergent, Globally Patterned Immune Responses in Murine Skin Inflammation. iScience. 2020 Sep. 23(10):101582. PMID: 33205009. PMCID: PMC7648132.

  23. Espinosa ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, Kim J, Walker CJ, Pontes DS, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J, Zhou XA. Progression of Cutaneous T-Cell Lymphoma after Dupilumab: Case Review of 7 Patients. J Am Acad Dermatol. 2020 Jul. 83(1):197-199. PMID: 32229275.

  24. Allen SD, Liu YG, Kim T, Bobbala S, Yi S, Zhang X, Choi J, Scott EA. Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis. Biomater Sci. 2019 Jan 2. 7(2):657-668. PMID: 30601470. 

  25. Lee D, Martinez-Escala ME, Serrano L, Zhou X, Kaplan J, Pro B, Choi J, Guitart J. Hemophagocytic lymphohistiocytosis in cutaneous T cell lymphoma. JAMA Derm. 2018 Jul;154 (7):828-831. PMID: 29874360.

  26. Martinez-Escala ME, Posiligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, Zhou XA, Kaplan JB, Pro B, Choi J, Querfeld C, Rosen ST, Guitart J. Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy. J Am Acad Dermatol. 2018 Jun; 78(6):1068-1076. PMID: 29307643. 

  27. Vandeven N, Lewis C, Makarov V, Riaz N, Paulson K, Hippe D, Bestick A, Doumani R, Marx T, Takagishi S, Chan T, Choi J, and Nghiem P. Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden and improved survival. Clin Cancer Res. 2018 Feb 15;24(4):963-971. PMID: 29246939. 

  28. Haugh AM, Zhang B, Quan VL, Garfield EM, Bubley JA, Kudalkar E, Verzi AE, Walton K, VandenBoom T, Merkel EA, Lee CY, Tan T, Isales MC, Kong BY, Wenzel AT, Bunick CG, Choi J, Sosman J, Gerami P. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure. J Invest Dermatol. 2018 Feb;138(2):384-393. PMID 28870692.

  29. Martinez-Escala ME, Kantor RW, Cices A, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J. CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. J Am Acad Dermatol. 2017 Sep; 77(3):489-496. PMID: 28676328.

  30. Weed J, Gibson J, Lewis J, Carlson K, Foss F, Choi J, Li P, Girardi. M. FISH panel for cutaneous T cell lymphoma. Journal of Invest Dermatol. 2017 Mar;137(3):751-753. PMID: 27836797.

  31. Zhang X, Rao A, Sette P, Deibert C, Pomerantz A, Kim WJ, Kohanbash G, Chang Y, Park Y, Engh J, Choi J, Chan T, Okada H, Lotze M, Grandi P, Amankulor N. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. Neuro Oncol. 2016 Oct; 18(10):1402-12. PMID: 27116977.

  32. Yelamos O, Merkel EA, Sholl LM, Zhang B, Amin SM, Lee CY, Guitart GE, Yang J, Wenzel AT, Bunick CG, Yazdan P, Choi J, Gerami P. Non-overlapping Clinical and Mutational Patterns in Melanomas From the Female Genital Tract and Atypical Genital Nevi. J Invest Dermatol. 2016 Sep; 136(9):1858-65. PMID: 27220476.

  33. Pinzaru A, Hom RA, Beal A, Philis AF, Ni E, Cardozo T, Nair N, Choi J, Wuttke DS, Sfeir A, Denchi EL. Telomere replication stress induced by POT1 inactivation accelerates tumorigenesis. Cell Rep. 2016 Jun 7;15(10):2170-84. PMID: 27239034. 

  34. Gibson JF, Huang J, Liu KJ, Carlson KR, Foss F, Choi J, Edelson R, Hussong JW, Mohl R, Hill S, Girardi M. Cutaneous T cell lymphoma: current practices in blood assessment and the utility of the T-cell receptor Vb chain restriction. Journal of Amer Acad Dermatol., 2016 May; 74(5):870-7. PMID: 26874819. 

  35. Ziai J, Matloff E, Choi J, Kombo N, Materin M, Bale AE. Defining the Polyposis/Colorectal Cancer Phenotype Associated with the Ashkenazi GREM1 Duplication: Counseling and Management Recommendations. Genet Res. 2016 Mar; 44(1):48-53. PMID: 27103854.

  36. Bi M, Zhao S, Said JW, Merino MJ, Abedowale JA, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Lifton RP, and Shuch, B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci., 2016 Feb; 113(8):2170-5. PMID: 26864202.

  37. Hosler GA, Davoli T, Mender I, Litzner B, Choi J, Kapur P, Shaw JW, and Wang RC. A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT. J Cutan Pathol. 2015 Feb;42(2):108-17 PMID: 25407517

  38. Futterleib JS, Feng H, Tigelaar RE, Choi J, Edelson RL. Activation of GILZ gene by photoactivated 8-methoxypsoralen: potential role of immunoregulatory dendritic cells in extracorporeal photochemotherapy. Transfus Apher Sci. 2014 Jun;50(3):379-387 PMID: 24215840

  39. Madge LA, Li JH, Choi J, Pober JS.  Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis.  J Biol Chem. 2003 Jun 6;278(23):21295-306. PMID: 12663669

Invited Reviews and Commentaries

  1. Zhang Y, Cheng K. Choi J*. Brief Review: TCR Mutations in Mature T Cell Lymphomas. J Immunol. 2023 Nov 15;211(10):1450-1458. PMID: 37931208. *corresponding author

  2. Zhang Y, LeWitt TM, Louissaint A Jr, Guitart J, Zhou XA, Choi J*. Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. J Invest Dermatol. 2023 Feb;143(2):189-196. PMID: 36163302. PMCID: PMC10260375. *corresponding author

  3. Ladomersky E, Scholtens DM, Kocherginsky M, Hibler EA, Bartom ET, Otto-Meyer S, Zhai L, Lauing KL, Choi J, Sosman JA, Wu JD, Zhang B, Lukas RV, and Wainwright DA. The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients with Glioblastoma. Frontiers in Pharmcology. 2019 Mar; PMID: 30971917. 

  4. Martinez-Escala ME, Choi J*. Are MicroRNAs Key to Developing Biomarkers for Cutaneous T-cell Lymphoma? J Invest Dermatol. 2018 Sep;138(9):1906-1908. PMID: 30143078. *corresponding author

  5. Sunshine J, Jahchan NS, Sage J, Choi J.* Are there Multiple Cells of Origin of Merkel Cell Carcinoma. Oncogene. 2018 Mar;37(11):1409-1416. PMID: 29321666. *corresponding author

    Featured in F1000Prime Article Recommendations.

  6. Chae YK, Arya A, Iams W, Cruz MR, Chandra S, Choi J, and Giles F. Current landscape and future of dual anti-CTLA-4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC). J Immunother Cancer. 2018 May; 6(1):39. PMID: 29769148.

  7. Chae YK, Arya A, Chiec L, Shah H, Rosenberg A, Patel S, Raparia K, Choi J, Wainwright DA, Villaflor V, Cristofanili M, Giles F. Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy? Oncotarget 2017 Aug 1; 8(59) 100863-100898. PMID: 29246028. 

  8. Zhou XA, Choi J.* Photopheresis for Scleroderma. Curr Rheumatol Rep. 2017 Jun; 19(6):31. PMID: 28466383. *corresponding author

  9. Malecek, MK, Robinson JK, Bilimoria K, Choi JN, Choi J, Gerami P, Kruser T, Kuzel T, Martini M, Strauss JB, Wayne J, Sosman J, and Chandra S. Advancements in unresectable melanoma: a multidisciplinary perspective. Melanoma Management. 2016 Sep; 3(3):171-175. PMID: 30190886.

  10. Damsky W., Choi J*. Genetics of cutaneous T cell lymphoma: from bench to bedside. Curr Treat Options Oncol. 2016 Jul; 17(7):33. PMID: 2762707. *corresponding author

  11. Lansigan, F, Choi J, Foss F.  Cutaneous T cell lymphoma. Hematol Oncol Clin North Am. 2008 Oct;22(5):979-96. PMID: 18954747

  12. Choi J, Foss F.  Cutaneous T cell lymphoma: Biologic targets for therapy. Curr Hematol Malig Rep. 2007 Oct;2(4):272-277. PMID: 20425380

  13. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. T lymphocyte-endothelial cell interactions. Annu Rev Immunol. 2004;22:683-709. PMID: 15032593

Books and Book Chapters

  1. Sokhn JG, Choi J, and Foss FM. Photopheresis. In: Wingard JR, Gastineau D, Leather H, Snyder EL, Szczepiorkowski ZM, eds. Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians, 2nd ed. Bethesda, MD: AABB Press, 2014.

  2. Choi J, Heald PW, Girardi M. Extracorporeal Photochemotherapy. In: Wolverton eds., Comprehensive Drug Therapy, 3rd ed. China: Elsevier-Saunders, 2012.

  3. Choi J, Foss FM. Photopheresis. In: McLeod B, Szczepiorkowski Z, Weinstein R, Winters J, eds. Apheresis: Principles and practice, 3rd ed. Bethesda, MD: AABB Press, 2010.

  4. Aasi S, Choi J. Dermatologic Diseases and Disorders. In: Pacala JT, Sullivan GM, eds. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine, 7th ed. New York, NY: American Geriatrics Society; 2008.

Case Reports, Letters, Editorials

  1. Snowden CS, Choi J*. Partial remission of advanced untreated Sezary Syndrome after COVID-19. JAAD Case Reports. 2022 Mar;21:165-168. *corresponding author
  2. Walker CJ, Donnelly ED, Moreira J, Mehta J, Mittal BB, Choi J, Zhou XA, Guitart J, Pro B. Pembrolizumab and pallitative radiotherapy in 2 cases of refractory mycosis fungoides. JAAD Case Reports. 2020 Nov 6;87-90.
  3. Choi J. Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/assessment-of-age-period-and-birth-cohort-effects-and-trends-in-merkel-cell-carcinoma-incidence-in-the-united-states/109107/65/4/1. Accessed December 04, 2020
  4. Choi J. Factors Associated With Time to Treatment for Merkel Cell Carcinoma. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/factors-associated-with-time-to-treatment-for-merkel-cell-carcinoma/109988/65/4/1. Accessed December 04, 2020

  5. Damsky, WE, Vesely, MD, Lee, AI, Choi J, Meyer, A, Chen, M, Ahmed, T, and King, BR. Drug induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib. JAAD Case Reports. 2019 Nov 13;5(12):1018-1026. PMID: 31763425.

  6. Damsky W., Craiglow B., Choi J*. A discordant cutaneous eruption in neonatal twins. JAMA Dermatol. 2016 Apr; 152(4):463-4. PMID: 26791600. *corresponding author

  7. Little AJ, Subtil A, Choi J*. Rapidly enlarging nodular plaque on the leg. JAMA Dermatol. 2014 Aug 13. PMID: 25133474. *corresponding author

  8. Ko CJ, Milstone LM, Choi J, McNiff JM. Pityriasis rubra pilaris: the clinical context of acantholysis and other histologic features. Int J Dermatol. 2011 Dec;50(12):1480-5.PMID: 22097993

  9. Choi J, Foss F. Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia. Yale J Biol Med. 2006 Dec; 79(3-4):169-72. PMID: 17940627